Literature DB >> 18200671

Enteral glutamine pretreatment does not decrease plasma endotoxin level induced by ischemia-reperfusion injury in rats.

Arda Demirkan1, Erkin Orazakunov, Berna Savaş, M Ayhan Kuzu, Mehmet Melli.   

Abstract

AIM: To investigate whether oral glutamine pretreatment prevents impairment of intestinal mucosal integrity during ischemia-reperfusion (I/R) in rats.
METHODS: The study was performed as two series with 40 rats in each. Each series of animals was divided into four groups. The first group was used as a control. Animals in the second group were only pretreated with oral glutamine, 1 g/kg for 4 d. The third group received a normal diet, and underwent intestinal I/R, while the fourth group was pretreated with oral glutamine in the same way, and underwent intestinal I/R. Intestinal mucosal permeability to (51)Cr-labeled EDTA was measured in urine in the first series of animals. In the second series, histopathological changes in intestinal tissue and plasma endotoxin levels were evaluated.
RESULTS: Intestinal I/R produced a significant increase in intestinal permeability, plasma endotoxin level and worsened histopathological alterations. After intestinal I/R, permeability was significantly lower in glutamine-treated rats compared to those which received a normal diet. However, no significant change was observed in plasma endotoxin levels or histopathological findings.
CONCLUSION: Although glutamine pretreatment seems to be protective of intestinal integrity, upon I/R injury, such an effect was not observable in the histopathological changes or plasma endotoxin level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18200671      PMCID: PMC2679137          DOI: 10.3748/wjg.14.463

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

Review 1.  The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure.

Authors:  E A Deitch
Journal:  Arch Surg       Date:  1990-03

Review 2.  Oxygen radicals in intestinal ischemia and reperfusion.

Authors:  M H Schoenberg; H G Beger
Journal:  Chem Biol Interact       Date:  1990       Impact factor: 5.192

Review 3.  Intestinal permeability: an overview.

Authors:  I Bjarnason; A MacPherson; D Hollander
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

Review 4.  Free radicals and other reactive oxygen metabolites: clinical relevance and the therapeutic efficacy of antioxidant therapy.

Authors:  G B Bulkley
Journal:  Surgery       Date:  1993-05       Impact factor: 3.982

5.  The effects of sepsis and endotoxemia on gut glutamine metabolism.

Authors:  W W Souba; K Herskowitz; V S Klimberg; R M Salloum; D A Plumley; T C Flynn; E M Copeland
Journal:  Ann Surg       Date:  1990-05       Impact factor: 12.969

6.  Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion.

Authors:  T R Harward; D Coe; W W Souba; N Klingman; J M Seeger
Journal:  J Surg Res       Date:  1994-04       Impact factor: 2.192

7.  Prevention of chronic radiation enteropathy by dietary glutamine.

Authors:  J C Jensen; R Schaefer; E Nwokedi; D W Bevans; M L Baker; A A Pappas; K C Westbrook; V S Klimberg
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

Review 8.  Reperfusion injury after intestinal ischemia.

Authors:  M H Schoenberg; H G Beger
Journal:  Crit Care Med       Date:  1993-09       Impact factor: 7.598

9.  Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.

Authors:  A K Banerjee; T J Peters
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

10.  Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation.

Authors:  V S Klimberg; R M Salloum; M Kasper; D A Plumley; D J Dolson; R D Hautamaki; W R Mendenhall; F C Bova; K I Bland; E M Copeland
Journal:  Arch Surg       Date:  1990-08
View more
  1 in total

1.  Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial.

Authors:  Jaya Benjamin; Govind Makharia; Vineet Ahuja; K D Anand Rajan; Mani Kalaivani; Siddhartha Datta Gupta; Yogendra Kumar Joshi
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.